Proteomic analysis of multiple sclerosis cerebrospinal fluid

Multiple Sclerosis

Volumn 10, Issue 3, 2004, Pages 245-260

  Hammack, Barbara N ^a   Fung, K Y C ^a   Hunsucker, S W ^a   Duncan, M W ^a   Burgoon, M P ^a   Owens, G P ^a   Gilden, D H ^a  

^a UNIVERSITY OF COLORADO   (United States)

Author keywords

Cerebrospinal fluid; Multiple sclerosis; Proteomics

Indexed keywords

BINDING PROTEIN; BRAIN PROTEIN; CALCIUM BINDING PROTEIN; CARTILAGE ACIDIC PROTEIN; GLYCOPROTEIN; PHOSPHODIESTERASE; PROTEOME; TETRANECTIN; UNCLASSIFIED DRUG;

ADULT; ARTICLE; CENTRAL NERVOUS SYSTEM DISEASE; CEREBROSPINAL FLUID ANALYSIS; CLINICAL ARTICLE; CONTROLLED STUDY; CORRELATION ANALYSIS; ENCEPHALITIS; FEMALE; HUMAN; MOLECULAR WEIGHT; MULTIPLE SCLEROSIS; PATHOGENESIS; PH; PROTEIN ANALYSIS; PROTEIN CEREBROSPINAL FLUID LEVEL; PROTEOMICS; TWO DIMENSIONAL GEL ELECTROPHORESIS;

ADULT; CEREBROSPINAL FLUID; ELECTROPHORESIS, GEL, TWO-DIMENSIONAL; FEMALE; HUMANS; MIDDLE AGED; MULTIPLE SCLEROSIS, RELAPSING-REMITTING; PEPTIDE MAPPING; PROTEOMICS; SPECTROMETRY, MASS, MATRIX-ASSISTED LASER DESORPTION-IONIZATION;

EID: 3042688356     PISSN: 13524585     EISSN: None     Source Type: Journal    
DOI: 10.1191/1352458504ms1023oa     Document Type: Article

References (16)

1. Kurtzke JF. On the time of onset in multiple sclerosis. Acta Neurol Scand 1965; 41: 140-58.
2. Kurtzke JF, Hyllested K. Multiple sclerosis in the Faroe Islands: I. Clinical and epidemiological features. Ann Neurol 1979; 5: 6-21.
3. Spielman RS, Nathanson N. The genetics of susceptibility to multiple sclerosis. Epidemiol Rev 1982; 4: 45-65.
4. Mattson DH, Roos RP, Arnason BGW. Comparison of agar gel electrophoresis and isoelectric focusing in multiple sclerosis and subacute sclerosing panencephalitis. Ann Neurol 1981; 9: 34-41.
5. Gilden DH, Devlin ME, Burgeon MP, Owens GP. The search for virus in multiple sclerosis brain. Mult Scler 1996; 2: 179-83.
6. Wasinger VC, Cordwell SJ, Cerpa-Poljak A, Yan JX, Gooley AA, Wilkins MR et al. Progress with gene-product mapping of the Mollicutes: Mycoplasma genitalium. Electrophoresis 1995; 16: 1090-94.
7. Davidsson P, Paulson L, Hesse C, Blennow K, Nilsson CL. Proteome studies of human cerebrospinal fluid and brain tissue using a preparative two-dimensional electrophoresis approach prior to mass spectrometry. Proteomics 2001; 1: 444-52.
8. Davidsson P, Westman-Brinkmalm A, Nilsson CL, Lindbjer M, Paulson L, Andreasen N et al. Proteome analysis of cerebrospinal fluid proteins in Alzheimer patients. Neuroreport 2002; 13: 611-15.
9. Yuan X, Russell T, Wood G, Desiderio DM. Analysis of the human lumbar cerebrospinal fluid proteome. Electrophoresis 2002; 23: 1185-96.
10. Bradford MM. A rapid and sensitive method for the quantitation of microgram quantities of protein utilizing the principle of protein-dye binding. Anal Biochem 1976; 72: 248-54.
11. Perkins DN, Pappin DJ, Creasy DM, Cottrell JS. Probability-based protein identification by searching sequence databases using mass spectrometry data. Electrophoresis 1999; 20: 3551-67.
12. Sickmann A, Dormeyer W, Wortelkamp S, Woitalla D, Kuhn W, Meyer H. Identification of proteins from human cerebrospinal fluid, separated by two-dimensional polyacrylamide gel electrophoresis. Electrophoresis 2000; 21: 2721-28.
13. Sickmann A, Dormeyer W, Wortelkamp S, Woitalla D, Kuhn W, Meyer HE. Towards a high resolution separation of human cerebrospinal fluid. J Chromatogr B Anal Technol Biomed Life Sci 2002; 771: 167-96.
14. Storch MK, Piddlesden S, Haltia M, Iivanainen M, Morgan P, Lassmann H. Multiple sclerosis: in situ evidence for antibody and complement-mediated demyelination. Ann Neurol 1998; 43: 465-71.
15. Kim JK, Mastronardi FG, Wood DD, Lubman DM, Zand R, Moscarello MA. Multiple sclerosis: an important role for post-translational modifications of myelin basic protein in pathogenesis. Mol Cell Proteomics 2003; 2: 453-62.
16. Yan Q, Sage EH. SPARC, a matricellular glycoprotein with important biological functions. J Histochem Cytochem 1999; 47: 1495-505.